300199.SZ · 翰宇药业
China A-shares · RS rating 88 · As of 2026-10-14
| Price | 24.88 CNY |
|---|---|
| 1-day change | -2.6% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 91 / 44 / 74 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 56 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +30.1% |
| Distance from 52-week high | +6.2% |
| Market cap (USD) | $3.1B |